The British Society of Toxicologic Pathology (BSTP) and The European Society of Toxicologic Pathology (ESTP) are pleased to invite you to the 2nd Joint BSTP/ESTP Toxicologic Pathology Congress entitled ‘Carcinogenicity in the 21st Century: Challenges of new methodologies, strategies, and their impact on pathologists’.
The congress takes place in Manchester, United Kingdom from 23rd to 26th September 2025.
Programme:
https://www.esvp-ecvp-estp-congress.eu/estp_congress/programme
Registration:
https://www.esvp-ecvp-estp-congress.eu/estp_congress/registration
For details, including how to submit abstracts for case presentations and posters, please visit the congress website: www.bstp-estp-congress.eu
In conjunction, an IATP symposium focusing on ‘Pathology Working Groups’ and an ESTP expert workshop on ‘Female Reproductive System’ will take place immediately before and after the congress, respectively, although separate registration will be needed for both events.
On behalf of the scientific organizing committee, it will be our pleasure and honor to welcome you all to the 2nd Joint BSTP/ESTP Toxicologic Pathology Congress in September 2025. We look forward to seeing you in Manchester!
With kind regards
Chairs of Scientific Organizing Committee
BSTP representatives
Jon Carter
Head of Pathology, Labcorp, United Kingdom
Zuhal Dincer
Head of Pathology Sciences, Sequani, United Kingdom
ESTP representatives
Thomas Nolte
NonClinical Safety and DMPK, Boehringer-Ingelheim, Germany
Ute Bach
Head of Pathology and Clinical Pathology, Bayer AG, Germany
Scientific Organizing Committee
Antonia Morey Matamalas, Charles River Laboratories, UK
Barbara Lenz, Roche, Switzerland
Cécile Sobry, Labo-Novaxia, France
Charlotte Dalsgaard, Novonordisk, Denmark
Dirk Schaudien, Fraunhofer ITEM, Germany
Emily Meseck, Novartis, USA
Fabienne Lien, Royal Veterinary College, UK
Frederic Schorsch, Bayer, France
Heike Marxfeld, Basf, Germany
Jacqui Stewart, Labcorp, UK
Laetitia Elies, Charles River Laboratories, France
Maike Huisinga, Basf, Germany
Matthew Jacobsen, AstraZeneca, UK
Sandra De Jonghe, Johnson&Johnson, Belgium
Sébastien Laurent, Sanofi, France
Shelley Patrick, Alnylam, USA
Xavier Palazzi, AstraZeneca, USA
Welcome_letter_2nd_announcement_BSTPESTP_2025_congress_19Feb2025.docx
Proposal_ESTP-BSTP_2025_Branding_-_Poster_FINAL.pdf